OMX-0407

N/A

Report date: 2026/04/25 20:00:23
NMEFirst In Class

Base Information

Drug NameOMX-0407
Drug Alias NameOMX-0407IMT-07
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSalt-inducible kinase 3 inhibitors
TargetsSalt-inducible kinase 3
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumGermanyFrance +[4] 
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIOmx Therapeutics AG
China Registration ClassN/A

Develop Information

Active CompaniesIOmx Therapeutics AG
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A